Symbol="ENOB"
AssetType="Common Stock"
Name="Enochian Biosciences Inc"
Description="Enochian Biosciences, Inc., a preclinical-stage biotechnology company, focuses on the development of human therapies for infectious diseases and cancers. The company is headquartered in Los Angeles, California."
CIK="1527728"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="DANDRIT BIOTECH A/S, FRUEBJERGVEJ 3 BOX 62, 2100 COPENHAGEN, DK"
FiscalYearEnd="June"
LatestQuarter="2023-03-31"
MarketCapitalization="44588700"
EBITDA="-20464270"
PERatio="None"
PEGRatio="None"
BookValue="1.14"
DividendPerShare="0"
DividendYield="0"
EPS="-2.07"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.0994"
ReturnOnEquityTTM="-0.939"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.07"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="None"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.45"
EVToRevenue="-"
EVToEBITDA="-1.727"
Beta="0.94"
num_52WeekHigh="2.99"
num_52WeekLow="0.393"
num_50DayMovingAverage="0.649"
num_200DayMovingAverage="1.139"
SharesOutstanding="63698000"
DividendDate="None"
ExDividendDate="None"
symbol="ENOB"
open="0.73"
high="0.74"
low="0.70"
price="0.70"
volume="88125.00"
latest_trading_day="2023-08-04"
previous_close="0.70"
change="0.00"
change_percent="0.0000%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="72"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="28"
Volume_recent_avg="182215"
Change_recent_avg="-0.01"
Delta_recent_avg="0.09"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-1.42"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="28"
Aroon_momentum_negative="72"
image_negative_thumbnail_id_1="1110"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0143.jpeg"
image_negative_thumbnail_id_2="129"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0047.jpeg"
image_neutral_thumbnail_id_1="589"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0010.jpeg"
image_neutral_thumbnail_id_2="556"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0043.jpeg"
image_positive_thumbnail_id_1="604"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0104.jpeg"
image_positive_thumbnail_id_2="656"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0052.jpeg"
image_professor_thumbnail_id_1="1197"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
image_professor_thumbnail_id_2="1179"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
